Our thoughts and prayers go out to all the family, friends and colleagues that have been affected by the ongoing events in Israel.
If you’d like to know more about what is happening, you can find live updates here.
Across Markets…
The Australian sharemarket was pushed higher on Monday by a sharp rally in energy and gold stocks as oil prices surged in Asia after Hamas’ bloody weekend incursions into Israel.
The benchmark S&P/ASX 200 added 16 points, or 0.2 per cent to 6970.2 at the closing bell after the shock attacks on Israel sent oil surging more than 4 per cent and investors piled into gold as a safe haven asset. The All Ordinaries rose 14 points to 7157.
A rally on Wall Street also buoyed the local sharemarket as investors shrugged off better-than-expected US jobs figures. The attacks on Israel occurred after the market had closed.
ING commodities strategist Warren Patterson says the heightened tensions in the Middle East region, combined with “the risk that the conflict could spread” means that investors “will remain nervous until there is a clear de-escalation.”
Gold stocks also advanced on the back of a spike in the precious metal price. Capricorn Metals jumped 5.4 per cent to $4.33, Newcrest increased 4.7 per cent to $25.42 and Regis firmed 5 per cent to $1.59. The price of gold climbed 0.9 per cent in Asia to $US1848.99 an ounce on the spot market.
Meanwhile, the major iron ore miners pared earlier gains, tracking the weakening in the iron ore price. BHP Group edged up 0.1 per cent to $44.03 and Fortescue shed 1.9 per cent to $20.67.
The $US rose against its major peers on Monday as currency traders got their first chance to react to the conflict. The greenback – long regarded as a haven in times of trouble – rose versus the euro and pound as trading began in Sydney.
Riskier currencies fell with the Australian dollar off 0.3 per cent to 63.66¢. That’s after falling 0.8 per cent last week to touch an 11-month low of 62.83¢.
Source: AFR
PharmAust (ASX: PAA) has confirmed positive top-line data from a Phase 2 veterinary clinical study of its lead candidate monepantel (MPL) for the treatment of canine B-cell lymphoma.
The study aimed to determine a clinically-safe and efficacious dosing regimen for the oral drug on 54 canines of mixed breeds.
It was found to be safe and well-tolerated and there were no treatment-related deaths or severe adverse reactions to the drug.
PharmAust said MPL had reached an overall clinical benefit of 35% (equating to 14 out of 40 dogs) with a median time to progression (TTP) of 28 days comparing favourably to Laverdia, which was recently approved by the US Food and Drug Administration (FDA) for B-cell and T-cell lymphoma in dogs.
TTP was defined as the time from the first date of treatment to the date the dog developed clinical or radiographic signs of progressive disease or died from any cause, including euthanasia.
The company plans to use the data to open an investigational new animal drug application with the FDA’s Centre for Veterinary Medicine (CVM).
Source: Small Caps
Sector: Lithium
Deal Type: Placement
Raise Amount: $1.75M
Latest Entry Price: $0.006 with a 1:2 AL8OA
Today’s Price Change: $0.014 +7.69%
Company: Terra Uranium (ASX:T92)
Sector: Uranium
Deal Type: IPO
Raise Amount: $7.5M
Latest Entry Price: $0.20
Today’s Price Change: $0.14 -6.67%
Company: Patagonia Lithium (ASX:PL3)
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.20
Today’s Price Change: $0.14 +7.69%
Company: Gold Mountain Limited (ASX:GMN)
Sector: Lithium
Deal Type: Placement
Raise Amount: $2.25M
Latest Entry Price: $0.0075
Today’s Price Change: $0.006 Unchanged
Company: Unith Ltd. (ASX:UNT)
Sector: AI/ChatGPT
Deal Type: Placement
Raise Amount: $4.5M
Latest Entry Price: $0.033 with a 1:1 UNTO
Today’s Price Change: $0.024 +4.35%
Company: Volt Resources Ltd. (ASX:VRC)
Sector: Battery Metals
Deal Type: Placement
Raise Amount: $5.75M
Latest Entry Price: $0.011
Today’s Price Change: $0.008 Unchanged
Company: Castle Minerals Ltd. (ASX:CDT)
Sector: Battery Metals/Base Metals
Deal Type: Placement
Raise Amount: $1.52M
Latest Entry Price: $0.02 with a 2:3 CDTOA
Today’s Price Change: $0.01 Unchanged
Company: Avenira Ltd. (ASX:AEV)
Sector: Phosphate
Deal Type: Placement
Raise Amount: $2.1M
Latest Entry Price: $0.01 with a 1:2 AEVO
Today’s Price Change: $0.01 -9.09%
Company: Latrobe Magnesium Ltd. (ASX:LMG)
Sector: Magnesium
Deal Type: Placement
Raise Amount: $3M & $11.5M
Latest Entry Price: $0.10 with a 1:4 LMGO
Today’s Price Change: $0.042 -2.33%
Company: Askari Metals Ltd (ASX:AS2)
Sector: Mining
Deal Type: IPO
Raise Amount: $5.7M
Latest Entry Price: $0.35 with a 1:3 AS2O
Today’s Price Change: $0.18 -2.70%
Company: iCandy (ASX:ICI)
Sector: Gaming & Digital Advertising
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.02 with a 1:1 ICIOB
Today’s Price Change: $0.037 Unchanged
Sector: Fintech
Deal Type: Placement
Raise Amount: $1.5M
Latest Entry Price: $0.015 with a 1:2 FFGOA
Today’s Price Change: $0.012 Unchanged
Company: Paradigm Biopharma (ASX:PAR)
Sector: Biopharma
Deal Type: IPO Cornerstone
Raise Amount: $1M+
Latest Entry Price: $0.35
Today’s Price Change: $0.59 Unchanged
Company: ReNu Energy Limited (ASX:RNE)
Sector: Energy
Deal Type: Placement
Raise Amount: $1.46M
Latest Entry Price: $0.06 with a 1:1 RNEO
Today’s Price Change: $0.029 Unchanged
Company: Carly Holdings Ltd (ASX:CL8)
Sector: AI and Car subscription
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.025 with a 1:2 CL8O
Today’s Price Change: $0.017 Unchanged
Sector: CBD
Raise Amount: $5M
Latest Entry Price: $0.006 with a 3:2 AVEOA
Today’s Price Change: $0.004 Unchanged
Sector: Medicinal Cannabis
Deal Type: Placement
Raise Amount: $6.6M
Latest Entry Price: $0.033 with 1:2 ECSO
Today’s Price Change: $0.023 -4.17%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak accepts no responsibility for any views expressed and marketing material contained in this email except where the message specifically states otherwise and the sender is authorised to state them to be the views of Peak. Information provided in this email is general advise only and does take account your objectives, financial situation or needs. Before acting on any advice in this email, Peak recommends that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, you should obtain the current Product Disclosure Statement (PDS) or other disclosure documents for the particular products and consider this information before making any decisions regarding the products. The Financial Services Guide (FSG) can be found at www.peakassetmanagement.com.au or by telephoning Peak on 1300 304 460
No responses yet